MY184483A - Ginsenoside fatty acid ester compound, method for preparing same, and cosmetic composition comprising same - Google Patents

Ginsenoside fatty acid ester compound, method for preparing same, and cosmetic composition comprising same

Info

Publication number
MY184483A
MY184483A MYPI2018700435A MYPI2018700435A MY184483A MY 184483 A MY184483 A MY 184483A MY PI2018700435 A MYPI2018700435 A MY PI2018700435A MY PI2018700435 A MYPI2018700435 A MY PI2018700435A MY 184483 A MY184483 A MY 184483A
Authority
MY
Malaysia
Prior art keywords
same
fatty acid
acid ester
ester compound
cosmetic composition
Prior art date
Application number
MYPI2018700435A
Inventor
Yong Deog Hong
Dong Hyun Kim
Jun Seong Park
Original Assignee
Amorepacific Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amorepacific Corp filed Critical Amorepacific Corp
Publication of MY184483A publication Critical patent/MY184483A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00—Preparation of steroids
    • C12P33/12—Acting on D ring
    • C12P33/16—Acting at 17 position

Abstract

The present invention relates to a ginsenoside fatty acid ester compound, a method for preparing thereof and a cosmetic composition comprising the same and, more specifically, to a ginsenoside fatty acid ester compound, modified into a fatty acid ester compound so as to have hydrophobicity, and a method for preparing the same. The compound shows excellent penetration ability through the corneum and effectively inhibits melanic pigment and MMP-1 expression, thereby being preferably applied as a cosmetic composition for skin whitening and wrinkle reduction.
MYPI2018700435A 2015-09-30 2016-08-30 Ginsenoside fatty acid ester compound, method for preparing same, and cosmetic composition comprising same MY184483A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020150137302A KR102029040B1 (en) 2015-09-30 2015-09-30 Ginsenoside fatty acid ester compounds, preparation method thereof, and cosmetic composition comprising the same
PCT/KR2016/009665 WO2017057851A1 (en) 2015-09-30 2016-08-30 Ginsenoside fatty acid ester compound, method for preparing same, and cosmetic composition comprising same

Publications (1)

Publication Number Publication Date
MY184483A true MY184483A (en) 2021-04-01

Family

ID=58427808

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2018700435A MY184483A (en) 2015-09-30 2016-08-30 Ginsenoside fatty acid ester compound, method for preparing same, and cosmetic composition comprising same

Country Status (8)

Country Link
KR (1) KR102029040B1 (en)
CN (1) CN108137640B (en)
AU (1) AU2016332770B2 (en)
HK (1) HK1255926A1 (en)
MY (1) MY184483A (en)
SG (1) SG11201800961YA (en)
TW (1) TWI717385B (en)
WO (1) WO2017057851A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111467358B (en) * 2020-03-31 2021-05-14 陕西巨子生物技术有限公司 Pharmaceutical composition containing ginsenoside Rh3, PPD and Rh2
KR102430732B1 (en) 2021-10-18 2022-08-10 (주)디아이지엔지니어링건축사사무소 Permanent soil barrier walls supporting civil engineering and building

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100485326B1 (en) 2002-12-26 2005-04-27 주식회사 태평양 Promoter for the production of hyaluronic acid containing ginsenoside compound K
KR101140039B1 (en) 2004-01-26 2012-05-02 (주)아모레퍼시픽 A composition that contains ginsenoside F1 and/or Compound K for skin external application
CN1300160C (en) * 2004-06-28 2007-02-14 吉林农业大学 Fatty acid ester compounds of ginsenoside secondary glycoside compound K and method for preparing same
CN100484951C (en) * 2004-12-01 2009-05-06 大连大学 Panaxcoside secondary glucoside fatty acid ester compound, its preparation method and medicinal composition using said compound as active ingredient
KR101127092B1 (en) * 2009-04-21 2012-03-23 한밭대학교 산학협력단 Preparation method of ginsenoside fatty acyl ester compound using lipase
KR101427572B1 (en) 2009-11-25 2014-08-08 (주)아모레퍼시픽 Skin external composition for promoting the production of hyaluronic acid containing ginsenoside Re and ginsenoside compound Ｋ
CN101880305B (en) * 2010-06-23 2012-09-05 大连大学 Preparation method of ginsenoside metabolin M1 fatty acid ester compound
CN102603847A (en) * 2010-11-18 2012-07-25 吉林农业大学 Preparation method and medicinal application of ginsenoside Rh2 aliphatic ester compound
CN102600189A (en) * 2011-01-24 2012-07-25 吉林农业大学 Application of ginseng secondary saponin and aliphatic ester derivative thereof in preventing and treating diabetes mellitus
KR101909533B1 (en) 2012-02-21 2018-10-19 (주)아모레퍼시픽 Composition of skin external application containing ginsenoside F1
KR20130115455A (en) * 2012-04-12 2013-10-22 (주) 비엔씨바이오팜 Composition for skin whitening and wrinkle improvement
KR20140013796A (en) 2012-07-27 2014-02-05 강원대학교산학협력단 Cosmetic composition comprising of gingenoside f1 for improving inflammatory diseases
KR101569089B1 (en) 2014-01-09 2015-11-13 경희대학교 산학협력단 Method for preparing ginsenoside derivative and composition comprising ginsenoside derivative prepared by the same for whitening and improving wrinkle

Also Published As

Publication number Publication date
HK1255926A1 (en) 2019-09-06
CN108137640B (en) 2021-09-07
CN108137640A (en) 2018-06-08
TWI717385B (en) 2021-02-01
AU2016332770B2 (en) 2020-08-06
TW201717903A (en) 2017-06-01
KR102029040B1 (en) 2019-10-07
WO2017057851A1 (en) 2017-04-06
AU2016332770A1 (en) 2018-01-25
KR20170038234A (en) 2017-04-07
SG11201800961YA (en) 2018-03-28

Similar Documents

Publication Publication Date Title
EP3269356A4 (en) Cosmetic composition for whitening skin and preparation method thereof
WO2017034367A3 (en) Composition for surface modification
IN2014DN09928A (en)
WO2013158380A3 (en) Hair care composition comprising metathesized unsaturated polyol esters
IN2014DN09931A (en)
MX2018004616A (en) Cosmetic composition having probiotic bacteria.
MY196718A (en) Composition for skin whitening comprising b-mangostin as effective ingredient
WO2016085127A3 (en) Stable peptide-conjugated ascorbic acid derivative, method for preparing same, and cosmetic composition containing same
WO2014026804A3 (en) Agent and method for the temporary deformation of keratin fibres
WO2017004282A8 (en) Musk compositions and methods of use thereof
BR112015029815A2 (en) cosmetic composition for lightening an individual's skin and / or hair, set for lightening an individual's skin and / or hair, cosmetic method for lightening an individual's skin and / or hair, cosmetic or pharmaceutical composition for application in skin, hair and / or nail of an individual, combined to apply a cosmetic or pharmaceutical composition to an individual's hair and / or nail skin and method of administering hydrogen peroxide to the individual's skin, hair and / or nail.
WO2016177908A3 (en) Process for treating keratin materials using amide, acid or ester c-glycoside derivatives, and cosmetic composition containing same
MX353580B (en) Monounsaturated fatty acid for preventing and/or treating skin complexion imperfections.
MY184483A (en) Ginsenoside fatty acid ester compound, method for preparing same, and cosmetic composition comprising same
MX2018002859A (en) Gardenia extract for colouring the skin.
MX2015016410A (en) Esters of oligo-hydroxycarboxylic acids and use thereof.
MX2015016490A (en) Sulfated oligohydroxycarboxylic acid esters, and use thereof.
MY184476A (en) Ginsenoside fatty acid ester compound, method for preparing same, and cosmetic composition comprising same
PL3365068T3 (en) Cosmetic compositions for skin whitening
WO2011113785A3 (en) A cosmetic composition for rejuvenating skin appearance
WO2017160694A3 (en) Compositions for providing vitamin d to the skin
IN2015MN00091A (en)
MY180409A (en) Deodorant composition and deodorant product comprising a deodorant composition
WO2012038289A3 (en) Method for straightening hair
EP3389613C0 (en) Cosmetic composition comprising an anionic surfactant, at least 3.5% by weight of a fatty acid and an antidandruff agent